DalsnaFinance › IPOs › Boundless Bio › IPO
Boundless Bio, Inc. completed its initial public offering on NASDAQ on March 28, 2024, pricing at $16.00 a share.
| Ticker | BOLD |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 28, 2024 |
| Offering price | $16.00 |
| Shares offered | 6,250,000 |
| Total raised | $100M |
Boundless Bio, Inc. sold 6,250,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $100 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $100 million total recorded for the deal.
Boundless Bio, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Boundless Bio, Inc.. This page is general information, not investment advice.